The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global IVD Infectious Diseases Market Research Report 2025
Synopsis
In Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to help detect infection, Diagnose a medical condition and Prevent disease.
The global IVD Infectious Diseases market was valued at US$ 16620 million in 2023 and is anticipated to reach US$ 22230 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.
North American market for IVD Infectious Diseases is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for IVD Infectious Diseases is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for IVD Infectious Diseases in Clinical Laboratories is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of IVD Infectious Diseases include BD, BioMerieux, Abbott, Quidel, Gen-Probe, Abbott, Danaher, Sysmex and Orasure, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for IVD Infectious Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IVD Infectious Diseases.
Report Scope
The IVD Infectious Diseases market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global IVD Infectious Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IVD Infectious Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
BioMerieux
Abbott
Quidel
Gen-Probe
Abbott
Danaher
Sysmex
Orasure
Hologic
Cepheid
Qiagen
Roche Diagnostics
Siemens Healthcare
Bio-Rad Laboratories
Segment by Type
Immunochemistry
Molecular Diagnostics
Segment by Application
Clinical Laboratories
Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of IVD Infectious Diseases companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
In Vitro Diagnostics (IVDs) are medical devices and accessories used to perform tests on samples, (e.g., blood, urine and tissue that has been taken from the human body) in order to help detect infection, Diagnose a medical condition and Prevent disease.
The global IVD Infectious Diseases market was valued at US$ 16620 million in 2023 and is anticipated to reach US$ 22230 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.
North American market for IVD Infectious Diseases is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for IVD Infectious Diseases is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for IVD Infectious Diseases in Clinical Laboratories is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of IVD Infectious Diseases include BD, BioMerieux, Abbott, Quidel, Gen-Probe, Abbott, Danaher, Sysmex and Orasure, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for IVD Infectious Diseases, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IVD Infectious Diseases.
Report Scope
The IVD Infectious Diseases market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global IVD Infectious Diseases market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IVD Infectious Diseases companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
BioMerieux
Abbott
Quidel
Gen-Probe
Abbott
Danaher
Sysmex
Orasure
Hologic
Cepheid
Qiagen
Roche Diagnostics
Siemens Healthcare
Bio-Rad Laboratories
Segment by Type
Immunochemistry
Molecular Diagnostics
Segment by Application
Clinical Laboratories
Diagnostic Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of IVD Infectious Diseases companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IVD Infectious Diseases Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Immunochemistry
1.2.3 Molecular Diagnostics
1.3 Market by Application
1.3.1 Global IVD Infectious Diseases Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Clinical Laboratories
1.3.3 Diagnostic Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global IVD Infectious Diseases Market Perspective (2019-2030)
2.2 IVD Infectious Diseases Growth Trends by Region
2.2.1 Global IVD Infectious Diseases Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 IVD Infectious Diseases Historic Market Size by Region (2019-2024)
2.2.3 IVD Infectious Diseases Forecasted Market Size by Region (2025-2030)
2.3 IVD Infectious Diseases Market Dynamics
2.3.1 IVD Infectious Diseases Industry Trends
2.3.2 IVD Infectious Diseases Market Drivers
2.3.3 IVD Infectious Diseases Market Challenges
2.3.4 IVD Infectious Diseases Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top IVD Infectious Diseases Players by Revenue
3.1.1 Global Top IVD Infectious Diseases Players by Revenue (2019-2024)
3.1.2 Global IVD Infectious Diseases Revenue Market Share by Players (2019-2024)
3.2 Global IVD Infectious Diseases Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by IVD Infectious Diseases Revenue
3.4 Global IVD Infectious Diseases Market Concentration Ratio
3.4.1 Global IVD Infectious Diseases Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IVD Infectious Diseases Revenue in 2023
3.5 IVD Infectious Diseases Key Players Head office and Area Served
3.6 Key Players IVD Infectious Diseases Product Solution and Service
3.7 Date of Enter into IVD Infectious Diseases Market
3.8 Mergers & Acquisitions, Expansion Plans
4 IVD Infectious Diseases Breakdown Data by Type
4.1 Global IVD Infectious Diseases Historic Market Size by Type (2019-2024)
4.2 Global IVD Infectious Diseases Forecasted Market Size by Type (2025-2030)
5 IVD Infectious Diseases Breakdown Data by Application
5.1 Global IVD Infectious Diseases Historic Market Size by Application (2019-2024)
5.2 Global IVD Infectious Diseases Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America IVD Infectious Diseases Market Size (2019-2030)
6.2 North America IVD Infectious Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America IVD Infectious Diseases Market Size by Country (2019-2024)
6.4 North America IVD Infectious Diseases Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe IVD Infectious Diseases Market Size (2019-2030)
7.2 Europe IVD Infectious Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe IVD Infectious Diseases Market Size by Country (2019-2024)
7.4 Europe IVD Infectious Diseases Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific IVD Infectious Diseases Market Size (2019-2030)
8.2 Asia-Pacific IVD Infectious Diseases Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific IVD Infectious Diseases Market Size by Region (2019-2024)
8.4 Asia-Pacific IVD Infectious Diseases Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America IVD Infectious Diseases Market Size (2019-2030)
9.2 Latin America IVD Infectious Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America IVD Infectious Diseases Market Size by Country (2019-2024)
9.4 Latin America IVD Infectious Diseases Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa IVD Infectious Diseases Market Size (2019-2030)
10.2 Middle East & Africa IVD Infectious Diseases Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa IVD Infectious Diseases Market Size by Country (2019-2024)
10.4 Middle East & Africa IVD Infectious Diseases Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Detail
11.1.2 BD Business Overview
11.1.3 BD IVD Infectious Diseases Introduction
11.1.4 BD Revenue in IVD Infectious Diseases Business (2019-2024)
11.1.5 BD Recent Development
11.2 BioMerieux
11.2.1 BioMerieux Company Detail
11.2.2 BioMerieux Business Overview
11.2.3 BioMerieux IVD Infectious Diseases Introduction
11.2.4 BioMerieux Revenue in IVD Infectious Diseases Business (2019-2024)
11.2.5 BioMerieux Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott IVD Infectious Diseases Introduction
11.3.4 Abbott Revenue in IVD Infectious Diseases Business (2019-2024)
11.3.5 Abbott Recent Development
11.4 Quidel
11.4.1 Quidel Company Detail
11.4.2 Quidel Business Overview
11.4.3 Quidel IVD Infectious Diseases Introduction
11.4.4 Quidel Revenue in IVD Infectious Diseases Business (2019-2024)
11.4.5 Quidel Recent Development
11.5 Gen-Probe
11.5.1 Gen-Probe Company Detail
11.5.2 Gen-Probe Business Overview
11.5.3 Gen-Probe IVD Infectious Diseases Introduction
11.5.4 Gen-Probe Revenue in IVD Infectious Diseases Business (2019-2024)
11.5.5 Gen-Probe Recent Development
11.6 Abbott
11.6.1 Abbott Company Detail
11.6.2 Abbott Business Overview
11.6.3 Abbott IVD Infectious Diseases Introduction
11.6.4 Abbott Revenue in IVD Infectious Diseases Business (2019-2024)
11.6.5 Abbott Recent Development
11.7 Danaher
11.7.1 Danaher Company Detail
11.7.2 Danaher Business Overview
11.7.3 Danaher IVD Infectious Diseases Introduction
11.7.4 Danaher Revenue in IVD Infectious Diseases Business (2019-2024)
11.7.5 Danaher Recent Development
11.8 Sysmex
11.8.1 Sysmex Company Detail
11.8.2 Sysmex Business Overview
11.8.3 Sysmex IVD Infectious Diseases Introduction
11.8.4 Sysmex Revenue in IVD Infectious Diseases Business (2019-2024)
11.8.5 Sysmex Recent Development
11.9 Orasure
11.9.1 Orasure Company Detail
11.9.2 Orasure Business Overview
11.9.3 Orasure IVD Infectious Diseases Introduction
11.9.4 Orasure Revenue in IVD Infectious Diseases Business (2019-2024)
11.9.5 Orasure Recent Development
11.10 Hologic
11.10.1 Hologic Company Detail
11.10.2 Hologic Business Overview
11.10.3 Hologic IVD Infectious Diseases Introduction
11.10.4 Hologic Revenue in IVD Infectious Diseases Business (2019-2024)
11.10.5 Hologic Recent Development
11.11 Cepheid
11.11.1 Cepheid Company Detail
11.11.2 Cepheid Business Overview
11.11.3 Cepheid IVD Infectious Diseases Introduction
11.11.4 Cepheid Revenue in IVD Infectious Diseases Business (2019-2024)
11.11.5 Cepheid Recent Development
11.12 Qiagen
11.12.1 Qiagen Company Detail
11.12.2 Qiagen Business Overview
11.12.3 Qiagen IVD Infectious Diseases Introduction
11.12.4 Qiagen Revenue in IVD Infectious Diseases Business (2019-2024)
11.12.5 Qiagen Recent Development
11.13 Roche Diagnostics
11.13.1 Roche Diagnostics Company Detail
11.13.2 Roche Diagnostics Business Overview
11.13.3 Roche Diagnostics IVD Infectious Diseases Introduction
11.13.4 Roche Diagnostics Revenue in IVD Infectious Diseases Business (2019-2024)
11.13.5 Roche Diagnostics Recent Development
11.14 Siemens Healthcare
11.14.1 Siemens Healthcare Company Detail
11.14.2 Siemens Healthcare Business Overview
11.14.3 Siemens Healthcare IVD Infectious Diseases Introduction
11.14.4 Siemens Healthcare Revenue in IVD Infectious Diseases Business (2019-2024)
11.14.5 Siemens Healthcare Recent Development
11.15 Bio-Rad Laboratories
11.15.1 Bio-Rad Laboratories Company Detail
11.15.2 Bio-Rad Laboratories Business Overview
11.15.3 Bio-Rad Laboratories IVD Infectious Diseases Introduction
11.15.4 Bio-Rad Laboratories Revenue in IVD Infectious Diseases Business (2019-2024)
11.15.5 Bio-Rad Laboratories Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global IVD Infectious Diseases Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Immunochemistry
Table 3. Key Players of Molecular Diagnostics
Table 4. Global IVD Infectious Diseases Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global IVD Infectious Diseases Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global IVD Infectious Diseases Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global IVD Infectious Diseases Market Share by Region (2019-2024)
Table 8. Global IVD Infectious Diseases Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global IVD Infectious Diseases Market Share by Region (2025-2030)
Table 10. IVD Infectious Diseases Market Trends
Table 11. IVD Infectious Diseases Market Drivers
Table 12. IVD Infectious Diseases Market Challenges
Table 13. IVD Infectious Diseases Market Restraints
Table 14. Global IVD Infectious Diseases Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global IVD Infectious Diseases Market Share by Players (2019-2024)
Table 16. Global Top IVD Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Infectious Diseases as of 2023)
Table 17. Ranking of Global Top IVD Infectious Diseases Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by IVD Infectious Diseases Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players IVD Infectious Diseases Product Solution and Service
Table 21. Date of Enter into IVD Infectious Diseases Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global IVD Infectious Diseases Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global IVD Infectious Diseases Revenue Market Share by Type (2019-2024)
Table 25. Global IVD Infectious Diseases Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global IVD Infectious Diseases Revenue Market Share by Type (2025-2030)
Table 27. Global IVD Infectious Diseases Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global IVD Infectious Diseases Revenue Market Share by Application (2019-2024)
Table 29. Global IVD Infectious Diseases Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global IVD Infectious Diseases Revenue Market Share by Application (2025-2030)
Table 31. North America IVD Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America IVD Infectious Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America IVD Infectious Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe IVD Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe IVD Infectious Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe IVD Infectious Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific IVD Infectious Diseases Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific IVD Infectious Diseases Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific IVD Infectious Diseases Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America IVD Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America IVD Infectious Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America IVD Infectious Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa IVD Infectious Diseases Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa IVD Infectious Diseases Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa IVD Infectious Diseases Market Size by Country (2025-2030) & (US$ Million)
Table 46. BD Company Detail
Table 47. BD Business Overview
Table 48. BD IVD Infectious Diseases Product
Table 49. BD Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)
Table 50. BD Recent Development
Table 51. BioMerieux Company Detail
Table 52. BioMerieux Business Overview
Table 53. BioMerieux IVD Infectious Diseases Product
Table 54. BioMerieux Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)
Table 55. BioMerieux Recent Development
Table 56. Abbott Company Detail
Table 57. Abbott Business Overview
Table 58. Abbott IVD Infectious Diseases Product
Table 59. Abbott Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)
Table 60. Abbott Recent Development
Table 61. Quidel Company Detail
Table 62. Quidel Business Overview
Table 63. Quidel IVD Infectious Diseases Product
Table 64. Quidel Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)
Table 65. Quidel Recent Development
Table 66. Gen-Probe Company Detail
Table 67. Gen-Probe Business Overview
Table 68. Gen-Probe IVD Infectious Diseases Product
Table 69. Gen-Probe Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)
Table 70. Gen-Probe Recent Development
Table 71. Abbott Company Detail
Table 72. Abbott Business Overview
Table 73. Abbott IVD Infectious Diseases Product
Table 74. Abbott Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)
Table 75. Abbott Recent Development
Table 76. Danaher Company Detail
Table 77. Danaher Business Overview
Table 78. Danaher IVD Infectious Diseases Product
Table 79. Danaher Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)
Table 80. Danaher Recent Development
Table 81. Sysmex Company Detail
Table 82. Sysmex Business Overview
Table 83. Sysmex IVD Infectious Diseases Product
Table 84. Sysmex Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)
Table 85. Sysmex Recent Development
Table 86. Orasure Company Detail
Table 87. Orasure Business Overview
Table 88. Orasure IVD Infectious Diseases Product
Table 89. Orasure Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)
Table 90. Orasure Recent Development
Table 91. Hologic Company Detail
Table 92. Hologic Business Overview
Table 93. Hologic IVD Infectious Diseases Product
Table 94. Hologic Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)
Table 95. Hologic Recent Development
Table 96. Cepheid Company Detail
Table 97. Cepheid Business Overview
Table 98. Cepheid IVD Infectious Diseases Product
Table 99. Cepheid Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)
Table 100. Cepheid Recent Development
Table 101. Qiagen Company Detail
Table 102. Qiagen Business Overview
Table 103. Qiagen IVD Infectious Diseases Product
Table 104. Qiagen Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)
Table 105. Qiagen Recent Development
Table 106. Roche Diagnostics Company Detail
Table 107. Roche Diagnostics Business Overview
Table 108. Roche Diagnostics IVD Infectious Diseases Product
Table 109. Roche Diagnostics Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)
Table 110. Roche Diagnostics Recent Development
Table 111. Siemens Healthcare Company Detail
Table 112. Siemens Healthcare Business Overview
Table 113. Siemens Healthcare IVD Infectious Diseases Product
Table 114. Siemens Healthcare Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)
Table 115. Siemens Healthcare Recent Development
Table 116. Bio-Rad Laboratories Company Detail
Table 117. Bio-Rad Laboratories Business Overview
Table 118. Bio-Rad Laboratories IVD Infectious Diseases Product
Table 119. Bio-Rad Laboratories Revenue in IVD Infectious Diseases Business (2019-2024) & (US$ Million)
Table 120. Bio-Rad Laboratories Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global IVD Infectious Diseases Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global IVD Infectious Diseases Market Share by Type: 2023 VS 2030
Figure 3. Immunochemistry Features
Figure 4. Molecular Diagnostics Features
Figure 5. Global IVD Infectious Diseases Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global IVD Infectious Diseases Market Share by Application: 2023 VS 2030
Figure 7. Clinical Laboratories Case Studies
Figure 8. Diagnostic Centers Case Studies
Figure 9. IVD Infectious Diseases Report Years Considered
Figure 10. Global IVD Infectious Diseases Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global IVD Infectious Diseases Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global IVD Infectious Diseases Market Share by Region: 2023 VS 2030
Figure 13. Global IVD Infectious Diseases Market Share by Players in 2023
Figure 14. Global Top IVD Infectious Diseases Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IVD Infectious Diseases as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by IVD Infectious Diseases Revenue in 2023
Figure 16. North America IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America IVD Infectious Diseases Market Share by Country (2019-2030)
Figure 18. United States IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe IVD Infectious Diseases Market Share by Country (2019-2030)
Figure 22. Germany IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific IVD Infectious Diseases Market Share by Region (2019-2030)
Figure 30. China IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America IVD Infectious Diseases Market Share by Country (2019-2030)
Figure 38. Mexico IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa IVD Infectious Diseases Market Share by Country (2019-2030)
Figure 42. Turkey IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia IVD Infectious Diseases Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. BD Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)
Figure 45. BioMerieux Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)
Figure 46. Abbott Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)
Figure 47. Quidel Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)
Figure 48. Gen-Probe Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)
Figure 49. Abbott Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)
Figure 50. Danaher Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)
Figure 51. Sysmex Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)
Figure 52. Orasure Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)
Figure 53. Hologic Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)
Figure 54. Cepheid Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)
Figure 55. Qiagen Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)
Figure 56. Roche Diagnostics Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)
Figure 57. Siemens Healthcare Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)
Figure 58. Bio-Rad Laboratories Revenue Growth Rate in IVD Infectious Diseases Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
